Top compounds associated with response to SMTNL2


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.033 0.3
mRNA WP1130 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA TGX221 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA CIL55 CTRPv2 pan-cancer AAC -0.068 0.3
mRNA skepinone-L CTRPv2 pan-cancer AAC 0.059 0.3
mRNA BRD9876 CTRPv2 pan-cancer AAC 0.044 0.3
mRNA niclosamide CTRPv2 pan-cancer AAC 0.041 0.3
mRNA NSC23766 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.037 0.3
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
Download CSV